Diabetics more likely to skip eye exams

Despite having a higher risk of developing serious eye diseases that could potentially rob them of their vision, nearly 60 percent of diabetics do not have yearly eye exams. Diabetics are at a greater risk of losing their vision to diabetic retinopathy and the disease can lead to additional blinding eye problems if not caught early and […]

New treatment for uveitis

A recent study published in the New England Journal of Medicine details the findings that the arthritis medication, adalimumab, can effectively treat uveitis. Researchers were looking to determine what effect adalimumab has on patients with uveitis. Adalimumab is a steroid-free, injection that has few side effects and is used to treat rheumatic diseases. 217 adults […]

Gene Transfer for Macular Degeneration

Researchers recently completed the Phase 1 clinical trial that was conducted to determine the long-term safety of gene transfer to treat neovascular age-related macular degeneration. Results were published in the Human Gene Therapy journal. There were 21 participants who had advanced neovascular age-related macular degeneration in the clinical trial. They received treatment in one eye […]

Mediterranean diet lessens AMD risk

The Mediterranean diet has long been lauded for its confirmed health benefits and now offering protection against age-related macular degeneration can be added to its list of benefits. Fruits, vegetables, whole grains, legumes, nuts, fish and limited red meat and butter are the hallmarks of the Mediterranean diet. The University of Coimbra in Portugal launched […]

Diabetes risk doubled with 2 sweet drinks daily

Regardless of whether you consume two or more 200 – milliliter servings of sugar sweetened drinks or artificially sweetened drinks on a daily basis, a recent study found that your risk of developing type 2 diabetes is almost doubled.  If your intake is more than 5 200 – milliliter servings a day then you have […]

Lutemax 2020 featured in R.B.I. Vision Performance

The results of the first LAMA (Lutein, Vision and Mental Acuity) study showed that the combination of three macular carotenoids – lutein, zeaxanthin, and mesozeaxanthin – may increase the macular pigment ocular density (MPOD) even faster than previous studies had demonstrated. This study showed that in just a period of eight weeks, the MPOD of study […]

Improved therapy for retinoblastoma patients

The addition of topotecan to a multi-drug chemotherapy helped to maintain high cure rates for the devastating eye cancer and helped preserve vision and reduced the likelihood of developing treatment-related leukemia. Results of the 10-year follow-up study were recently published online in the Journal of Clinical Oncology. Retinoblastoma is an eye cancer that occurs in […]

Warning for stroke patients with wet AMD

Patients suffering from wet macular degeneration who have had a stroke are being warned against using bevacizumab (Avastin®) within a 6 month period after the stroke. This is because people who had a bevacizumab eye injection within 3 to 6 months after a stroke had a significantly higher mortality rate than patients who did not receive injections. […]

Lucentis Prefilled Syringe approved by FDA

Doctors will now have an alternative when it comes to administering Lucentis injections for patients with advanced macular degeneration or diabetic retinopathy. The FDA recently announced its approval of .5 mg pre-filled syringes of Luncentis for the treatment of patients with wet age-related macular degeneration, macular edema and retinal vein occlusion. Currently, physicians have several […]

Testing blood sugar with a contact lens

For diabetics who must endure blood testing to check their glucose levels, a pain-free method may soon be available in the form of a contact lens. Researchers at the University of Houston published results of a study in the journal Advanced Materials. Armed with the knowledge that glucose is present in blood as well as […]